SCHEMBL16633428

SCHEMBL16633428

CN(C)C(=O)CC(c1ccc(OC(F)(F)F)cc1)N(C(=O)O)C(C)(C)C

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.38
BCHE P06276 1/20 0.38
ACHE P22303 1/20 0.38
LIPE Q05469 1/20 0.38
SLC6A2 P23975 1/20 0.37
SLC6A4 P31645 1/20 0.37
GRIN2B Q13224 1/20 0.36
POLB P06746 1/20 0.36
CCR5 P51681 1/20 0.36
MMP2 P08253 2/20 0.36
MMP9 P14780 2/20 0.36
OPRM1 P35372 1/20 0.36
PPARG P37231 1/20 0.36
PPARD Q03181 1/20 0.36
PPARA Q07869 1/20 0.36
EPHX1 P07099 2/20 0.36
SERPINE1 P05121 1/20 0.36
PDE2A O00408 2/20 0.35
CYP2C8 P10632 1/20 0.35
CYP2C9 P11712 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16632995 0.86 EPHX1 (0.41) ALDH1A1SLC6A2SLC6A4MMP2MMP9
SCHEMBL16633204 0.85 MMP2 (0.40) ALDH1A1BCHEACHELIPESLC6A2
SCHEMBL16633980 0.85 ALDH1A1 (0.41) ALDH1A1POLBMMP2MMP9PPARA
SCHEMBL16634078 0.84 EPHX1 (0.40) ALDH1A1SLC6A2SLC6A4POLBMMP2
SCHEMBL16633307 0.81 ALDH1A1 (0.38) ALDH1A1POLBMMP2MMP9OPRM1
SCHEMBL16633172 0.81 ALDH1A1 (0.38) ALDH1A1POLBMMP2MMP9EPHX1
SCHEMBL16633394 0.79 ALDH1A1 (0.38) ALDH1A1BCHEACHELIPESLC6A2
SCHEMBL16633119 0.78 SLC6A4 (0.47) SLC6A2SLC6A4OPRM1CYP2C19EPHX2
SCHEMBL12836836 0.78 ALDH1A1 (0.46) ALDH1A1BCHEACHELIPESLC6A2
Hydrochloric Acid SCHEMBL16564076 0.76 ALDH1A1 (0.41) ALDH1A1SLC6A2SLC6A4GRIN2BPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9469637-B2 Nitrogenated heterocyclic compound TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2016-10-18 US disclosed
US-20150105373-A1 NITROGENATED HETEROCYCLIC COMPOUND TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2015-04-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150105373-A1 NITROGENATED HETEROCYCLIC COMPOUND PDE2A, PDE5A, PDE3A ALDH1A1 492/4885BCHE 198/4885ACHE 24/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.